Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Exercise or conversion Director acquired 732 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 732 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale Director sold 15,000 shares at an average $110.92 ($1,663,855)
  10. 4 Planned sale Director sold 15,000 shares at an average $108.32 ($1,624,836)
  11. 4 Planned sale Director sold 15,000 shares at an average $103.38 ($1,550,703)
  12. 4 Planned sale President sold 15,000 shares at $105.02 ($1,575,300)
  13. 4 Planned sale Director sold 15,000 shares at an average $107.12 ($1,606,865)
  14. 4 Planned sale Chief Financial Officer sold 705 shares at $101.93 ($71,859)
  15. 4 Planned sale Director sold 15,000 shares at an average $101.68 ($1,525,268)
  16. 4 Planned sale Director sold 15,000 shares at an average $109.06 ($1,635,864)
  17. 4 Planned sale Director sold 15,000 shares at an average $102.39 ($1,535,820)
  18. 4 Planned sale President sold 15,000 shares at $103.17 ($1,547,550)
  19. 4 Planned sale Director sold 15,000 shares at an average $108.54 ($1,628,031)
  20. 4 Planned sale Chief Legal Officer sold 544 shares at $99.05 ($53,884)

Page 9 of 54 · 1,067 filings